Crinetics Pharmaceuticals, Inc. (CRNX)
84.78
+0.09
(+0.11%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
+0.01
(+0.01%)
After-Hours: 20:00
Crinetics Pharmaceuticals Shareholders Equity (Quarterly) : 1.192B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.192B |
| March 31, 2026 | 1.281B |
| December 31, 2025 | 992.08M |
| September 30, 2025 | 1.072B |
| June 30, 2025 | 1.172B |
| March 31, 2025 | 1.254B |
| December 31, 2024 | 1.325B |
| September 30, 2024 | 832.98M |
| June 30, 2024 | 830.76M |
| March 31, 2024 | 874.93M |
| December 31, 2023 | 539.11M |
| September 30, 2023 | 547.75M |
| June 30, 2023 | 254.12M |
| March 31, 2023 | 280.33M |
| December 31, 2022 | 316.33M |
| September 30, 2022 | 351.37M |
| June 30, 2022 | 386.16M |
| March 31, 2022 | 303.04M |
| Date | Value |
|---|---|
| December 31, 2021 | 331.94M |
| September 30, 2021 | 193.59M |
| June 30, 2021 | 201.44M |
| March 31, 2021 | 149.48M |
| December 31, 2020 | 168.92M |
| September 30, 2020 | 187.22M |
| June 30, 2020 | 202.77M |
| March 31, 2020 | 108.44M |
| December 31, 2019 | 117.14M |
| September 30, 2019 | 129.52M |
| June 30, 2019 | 142.10M |
| March 31, 2019 | 152.39M |
| December 31, 2018 | 160.22M |
| September 30, 2018 | 167.52M |
| June 30, 2018 | 67.80M |
| March 31, 2018 | 73.00M |
| December 31, 2017 | 14.68M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Pfizer Inc. | 85.19B |
| Bristol Myers Squibb Co. | 22.32B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.322B |
| Total Liabilities (Quarterly) | 129.92M |
| Debt to Equity Ratio | 0.0396 |
| Current Ratio | 15.57 |
| Net Debt Paydown Yield | 0.02% |